IGM Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2.63 |
9.25 |
13.56 |
13.95 |
4.85 |
6.08 |
| Przychód Δ r/r |
0.00% |
251.49% |
46.60% |
2.88% |
-65.23% |
25.36% |
| Przychód (min) |
2.06 |
1.29 |
3.60 |
3.70 |
1.29 |
1.61 |
| Przychód (max) |
3.36 |
17.45 |
27.65 |
28.44 |
9.89 |
12.40 |
| EBITDA (średnia) |
-0.53 |
-1.85 |
-2.71 |
-2.79 |
-0.97 |
-1.22 |
| EBIT (średnia) |
-0.53 |
-1.85 |
-2.71 |
-2.79 |
-0.97 |
-1.22 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-185.38 |
-99.92 |
-34.36 |
-34.89 |
-30.86 |
-22.39 |
| Zysk netto % |
-7044.13% |
-1080.25% |
-253.39% |
-250.10% |
-636.34% |
-368.26% |
| EPS (średnia) |
-3.06 |
-1.65 |
-1.40 |
-1.62 |
-0.51 |
-0.37 |
| Liczba analityków (Przychody) |
8 |
3 |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
6 |
4 |
1 |
1 |
1 |
1 |
| symbol |
IGMS |
IGMS |
IGMS |
IGMS |
IGMS |
IGMS |